https://orcid.org/0000-0003-4067-7860
Figures
Abstract
HIV Pre-exposure prophylaxis (PrEP) is an effective prevention tool, but there are still few studies about PrEP uptake among adolescents. We aimed to analyze the PrEP uptake process and factors associated with daily oral PrEP initiation among adolescent men who have sex with men (aMSM) and transgender women (aTGW) in Brazil. Baseline data from the first demonstration PrEP cohort study among aMSM and aTGW 15–19 years old (yo) ongoing in three large Brazilian cities (PrEP1519). After completing informed consent procedures, participants were enrolled in the cohort from February/2019 to February/2021. A socio-behavioral questionnaire was applied. Factors associated with PrEP initiation were assessed using a logistic regression model with adjusted prevalence ratios (aPR) and 95% confidence intervals (95%CI). Among recruited participants, 174 (19,2%) were aged 15–17 yo and 734 (80,8%) 18–19 yo. The rate of PrEP initiation was 78.2% and 77.4% for 15–17 yo and 18–19 yo, respectively. Factors associated with PrEP initiation were: black or mixed race (aPR 2.31; 95%CI: 1.10–4.84) among the younger adolescents 15–17 yo; experienced violence and/or discrimination due to their sexual orientation or gender identity (aPR 1.21; 95%CI: 1.01–1.46); transactional sex (aPR 1.32; 95%CI: 1.04–1.68); and having had between 2 to 5 sexual partners in the previous three months (aPR 1.39; 95%CI: 1.15–1.68) among those 18–19 yo. Unprotected receptive anal intercourse in the previous six months was associated with PrEP initiation in both age groups (aPR 1.98; 95%CI: 1.02–3.85 and aPR 1.45; 95%CI: 1.19–1.76 among 15–17 yo and 18–19 yo, respectively). The biggest challenge to promoting PrEP use for aMSM and aTGW was in the first steps of the PrEP uptake process. Once they were linked to the PrEP clinic, initiation rates were high.
Citation: Soares F, Magno L, Eustorgio Filho M, Duarte FM, Grangeiro A, Greco D, et al. (2023) Important steps for PrEP uptake among adolescent men who have sex with men and transgender women in Brazil. PLoS ONE 18(4): e0281654. https://doi.org/10.1371/journal.pone.0281654
Editor: Jill Blumenthal, University of California San Diego, UNITED STATES
Received: October 21, 2021; Accepted: January 29, 2023; Published: April 4, 2023
Copyright: © 2023 Soares et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Dataset analyzed that underlie the results reported of the article "Important steps for PrEP uptake among adolescents´ men who have sex with men and transgender women in Brazil" is available on Harvard Dataverse, V1, with doi.org/10.7910/DVN/OMZUQV. Named file: "Dataset - Important steps for PrEP uptake among adolescents MSM and TGW".
Funding: This study was provided by the Department of Chronic Conditions and Sexually Transmitted Infections/Brazilian Ministry of Health, and the Unitaid (Grant number 2017-15-FIOTEC PrEP). The Unitaid accelerates access to innovative health products and lays the foundations for their scale-up by countries and partners. Unitaid is a hosted partnership of WHO. The funders had no role in study design, data collection, and analysis, decision to publish, or manuscript preparation.
Competing interests: The authors have declared that no competing interests exist.
Introduction
In Brazil, the HIV epidemic disproportionately affects gays and other men who have sex with men (MSM) and transgender women (TGW) [1–5]. Studies show that these populations face barriers to gaining access to HIV prevention and care services [5–7]. In Brazil, respondent-driven sampling (RDS) surveys reported a high prevalence of HIV among adults MSM [8, 9] and TGW [1, 10], approaching 18% and 30%, respectively. In recent years, an increase in HIV incidence among young and adolescent MSM and TGW have been observed [11–14]. In addition, recent data from the Brazilian Ministry of Health Epidemiological Bulletin, based on cases reported in health care services, show an increase of 64.9% and 74.8% in AIDS incidence rates among young men aged 15 to 19 years and 20 to 24 years, respectively, from 2009 to 2019. In 2019, the highest estimated rate was 52.0 cases per 100,000 among people aged 25 to 29 years, which exceeded the rates in men aged 30 to 39 years, which were higher until 2015. And an increased trend from 2000 onwards is observed among adolescents from key populations (KP), such as MSM and TGW [15].
Despite these alarming statistics, there has been a dearth of effective HIV prevention interventions for this population [16]. Among adolescent MSM (aMSM) and TGW (aTGW), many intersecting vulnerabilities expose them to greater HIV risk [14], amongst them discrimination due to their sexual orientation and gender identity, experiences of stigma and violence [17–19], socioeconomic and political power inequalities [19, 20], and low access to education, especially to sex education specific to sexual or gender minorities youth [16, 20, 21].
Daily oral pre-exposure prophylaxis (PrEP) is an effective component of combination HIV prevention and is based on the use of an oral fixed-dose of a combination of nucleoside analogs antiretroviral-tenofovir (TDF) and emtricitabine (FTC), co-formulated in a single pill. The World Health Organization (WHO) recommends PrEP for adults and adolescent MSM and TGW at increased risk for HIV infection as an additional prevention strategy [22, 23]. Its high efficacy has been proven in clinical trials upon adherence to daily pill use [24–26]. In demonstration trials, PrEP was shown effective and safe for HIV prevention among MSM and TGW adults and adolescents [27–29].
PrEP was introduced in the Brazilian National Health System (in Portuguese–Sistema Único de Saúde—SUS) in late 2017 for population groups at a higher risk of infection [30]. PrEP is also safe and effective for adolescents from key populations (KP) [31] and was approved for adolescents by the US Food and Drug Administration in 2018 [32]. Recently, in 2022, it was released in Brazil for these adolescents and other people who are at risk for HIV infection over 15 years old, weighing at least 35 kg (77 lb).
PrEP access and use are processes that involve different steps, from assessing the HIV risk of potential users, promoting information, accessing and connecting them to health services, to prescribing and beginning use (PrEP uptake process) [33, 34].
Currently, PrEP prescriptions are suggested on the same day as the clinical checkup takes place, with a negative rapid test for HIV, while waiting for the results of safety laboratory tests is not mandatory [30, 35]. This strategy is considered safe and adopted by PrEP programs in Latin American countries and the United States of America (USA), in addition to being effective for the expansion of PrEP uptake [36–40].
However, there is limited knowledge about PrEP uptake among adolescent MSM and TGW. Studies with this population are still scarce and have small sample sizes [41–43], especially among adolescents younger than 18 years old (yo). The decision to use PrEP is determined by factors related to the prophylaxis characteristics and a set of individual, family, interpersonal, contextual, and structural conditions [44]. Thus, different age groups of adolescents will have different experiences and considerations about PrEP, and specific factors may be associated with PrEP initiation according to age groups. This article aims to describe the PrEP uptake process and analyze predictors for PrEP initiation among adolescent MSM and TGW in Brazil.
Material and methods
Study design
For this analysis, we used data from the baseline of the PrEP1519 study, the first cohort to demonstrate the effectiveness of PrEP in Brazil among aMSM and aTGW 15–19 year old at high risk of HIV infection, ongoing in three major Brazilian capitals: in Salvador (located at a Diversity Center that advocates for the rights of Lesbian, Gay, Bisexual, Transgender, Queer, Intersexual, Asexual and others (LGBTQIA+), in Belo Horizonte (located at a youth reference center), and in São Paulo (located in an HIV testing and counseling center), the last two in the public health system. The location of the PrEP clinics was carefully chosen, considering the accessibility and demands of sexual minorities adolescents to facilitate their access and linking to the services.
The eligibility criteria for enrollment in the cohort were: self-identification as MSM or TGW; 15–19 years old at the time of the study admission; sexual practices with cisgender men, and/or TGW; reside, work or study in one of the study cities, and test HIV negative at the time of enrollment. MSM and TGW were excluded if they were under the effect/influence of drugs and alcohol during the interview or had a mental illness that made it difficult to understand the research questions and the need for daily PrEP use. Upon eligibility criteria and the proposed steps for the study were informed, those who agreed to participate signed an informed consent (according to the court orders decisions defined for each city), were tested at the initial visit (baseline) for HIV using a 4th generation Rapid Test (Ag/Ab) followed by another 3rd generation Rapid Test and serological tests for other sexually transmitted infections (STIs). Participants self-selected into one out of two arms to participate in the study: (a) the PrEP arm included those that enrolled in daily use of oral PrEP with the TDF/FTC combination; (b) the non-PrEP arm included those who were not eligible for PrEP, and those who were eligible but chose not to use the prophylaxis and opted to receive only other HIV combination prevention methods (counseling, condoms, lubricant, HIV post-exposure prophylaxis (PEP) and HIV self-test).
After enrollment in the cohort, the participants were followed by a multidisciplinary team composed of physicians, nurses, social workers, psychologists, and pharmacists on regular visits or visits scheduled by the adolescents´ demand. The participants are also assigned a study peer-navigator and are monitored by the health team. These activities take place in person, via smartphone, and over WhatsApp, Instagram, and Facebook messages.
Theoretical framework
The PrEP uptake amongst adolescents in this study included necessary steps before PrEP initiation: (i) Facilitating PrEP access–strategies that facilitate access to PrEP for adolescents at higher risk of HIV; (ii) Linking to PrEP care–linking to the study PrEP clinics; (iii) Intention to use PrEP–willingness to use PrEP; (iv) Eligible for PrEP–meeting the clinical criteria for PrEP use; (v) Initiating PrEP–the adolescent possesses the PrEP pills and starts using them (adapted from Nunn [34]). Next, we describe the PrEP uptake process for participants enrolled in PrEP.
Facilitating PrEP access.
The aMSM and aTGW were recruited by young peer educators (PE) through different strategies: mobilization activities in places where adolescents meet, such as high schools, universities, public squares, bars, parks and beaches; intervention on social media such as Instagram, Facebook, WhatsApp, Twitter, Youtube; as well as hook-up apps such as Grindr, Tinder, and Badoo. During recruitment, the PE guided on the importance of combined HIV prevention, PrEP, scheduled clinical checkups, and guidance on how to get to the service. In addition, adolescents could also spontaneously attend clinics or were referred by other health services, friends, sexual partners, and Non-Governmental Organizations (NGOs) LGBTQIA+ [45]. Recruited aMSM and aTGW who arrived at PrEP clinics and underwent clinical examination by members of the multidisciplinary team for HIV risk and vulnerability assessments, counseling on combination prevention and clinical follow-up. During scheduled visits, participants had available reimbursement of BRL 30.00 for transportation and food costs.
Linking to PrEP care.
Upon enrolling in the project, the adolescents were assisted by a multidisciplinary team and were instructed about HIV prevention measures, including PrEP. The most appropriate prevention strategies for each adolescent were evaluated during clinical care, along with the participants, based on their vulnerability to STIs, clinical condition, and willingness to use them. At this time, participants could choose to enroll in the PrEP or non-PrEP arm.
Intention to use PrEP.
Participants were asked about their willingness to use PrEP during clinical care after the provider explained the PrEP use, side effects, and effectiveness.
PrEP eligibility.
For PrEP initiation, besides the intention to use, the participants had to meet clinical criteria, which includes at least one of the following: unprotected anal sex in the last six months, episode of STI and use of HIV PEP in the last 12 months, frequent use of alcohol or drugs before or during sexual intercourse (chemsex), reports of transactional sex (sex in exchange for money or favors), or any specific situation shared between the adolescent and interviewer, considered vulnerable to HIV and other STIs. Those who have renal impairment (defined by Glomerular Filtration Rate < 60 ml/min/1.75m2, using the Cockcroft-Galt formula for people over 17 years and Schwartz formula for people under 17 years), history of spontaneous bone fracture, clinical condition suggesting acute retroviral syndrome in the last 30 days or risky sexual intercourse in the last 72 hours, in the latter case, immediately referred for PEP use and were temporarily or permanently excluded from the group using PrEP. Laboratory and clinical criteria were evaluated after 30 days, with the availability of results.
Prescribing and initiating PrEP.
Participants eligible for PrEP who chose to use it initiated PrEP on the same day of their first visit to the clinic. The PrEP prescription happens after the rapid test for HIV, with a non-reactive result, and the collection of biological material for tests to monitor the safety of drug use. During the clinical visit, health professionals advise participants on the importance of adherence and side effects, answer questions and concerns about using of PrEP. At the end of the visit, adolescents received a PrEP prescription and a bottle with 30 pills for one month. Follow-up visits were scheduled quarterly after the first visit (three months, six months, nine months, and so on).
Data collection
This analysis used the cohort baseline data from February 2019 to February 2021 and three sources of information: a) participant registration form with sociodemographic information filled out upon admission to the PrEP clinic; b) clinical eligibility form filled out during the clinical checkup that assessed the eligibility and intention to use PrEP; and c) the socio-behavioral questionnaire with information regarding lifestyles, sexual practices, experiences of discrimination and violence, and preventive methods for STIs, applied in the clinics by an interviewer, or self-administered by the participant if they choose to do so or because of the COVID-19 contingency plan [46].
Study variables
The outcome variable was PrEP initiation defined by inclusion into the PrEP arm (PrEP prescription). The predictor variables for PrEP initiation were:
1. Sociodemographic: age (15 to 17 years; 18 and 19 years), a subpopulation (MSM; TGW), race/skin color (black—black and brown; non-black); schooling (at primary school; high school; higher education) and study site (Salvador, São Paulo, and Belo Horizonte); 2. Sexual behavior: unprotected sex at sexual debut (yes; no); unprotected anal sex in the last 6 months (yes; no); previous PEP use (yes; no);perceived risk of HIV infection on a scale of 0 to 10 (low—0 to 2; moderate—3 to 5; high—6 to 10); transactional sex in the previous three months (yes; no); use of hook-up apps in the previous three months (yes;no); an STI episode in the last 12 months (yes; no); frequent use of alcohol and/or drugs before or during sexual intercourse (yes; no); number of male casual partners in the previous three months (0 or 1; 2 to 5; 6 or more);3. Violence and discrimination: frequent experience of violence and discrimination due to sexual orientation or gender identity (yes; no); experience of sexual violence in a lifetime (yes; no).
Data analysis
A descriptive analysis of the study population was conducted, as well as a bivariate analysis of sociodemographic and behavioral variables with PrEP initiation, stratified by the two age brackets. The variables with a p-value ≤0.05 or defined as relevant by their magnitude in the bivariate analysis were included in the final models. In the evaluation of the predictors of PrEP initiation, we fitted independent models yielding prevalence ratios (PR) and respective 95% confidence intervals (CI) using logistic regression models and the delta method for CI estimation [47]. Multicollinearity was analyzed using association tests between selected covariates for the models, and the adequacy of the final models was analyzed using the Hosmer-Lemeshow goodness-of-fit test [48], considering a cutoff p value of 0.05.
Ethical consideration
The PrEP1519 study was conducted in accordance with the Brazilian (Resolution CNS no. 466, Brazil, 2012) and international research ethics guidelines, and it was approved by the ethics research committees (ERC) of the World Health Organization, Federal University of Bahia (#3,224,384), University of São Paulo (#3,082,360), and Federal University of Minas Gerais (#2,027,889). Written informed consent (WIC) was signed by 18 and 19-years old adolescents. For those aged <18 years, each city followed a different protocol according to local court decisions: for Belo Horizonte the WIC was signed by the parents or guardian as mandatory, followed by the assent form (AF) signed by the adolescents; for Salvador, there were two possibilities: i) the WIC was signed by a parent or guardian and the AF by the adolescent, or ii) the adolescent signed only the AF in cases in which the team’s psychologist and social worker judged that the family ties of the individual were broken or that the individual was at risk of physical, psychological, or moral violence due to the individual’s sexual orientation; and for São Paulo, only the AF was signed by the adolescents. All participants could withdraw consent at any stage of the process or skip any questions perceived as too sensitive, personal, or distressing. The data were stored in a secured database, and no personally identifiable information was used for any public presentation or publication to guarantee confidentiality.
Results
Nine hundred-eight adolescents were linked to PrEP care and enrolled in the study. Among all adolescents linked to the PrEP clinic, 174 (19.2%) were between 15 and 17 years old, and 734 (80.8%) were between 18 and 19 years old. The majority self-identified as MSM (86.8% and 93.6%, respectively), as black (70.1% and 67.8%, respectively) and attended high school (74.7% and 66.2%, respectively). Other reported sexual behavior variables: frequent use of alcohol and/or drugs before or during sexual intercourse (31.5% and 32.5%, respectively); frequent experience of violence and discrimination due to sexual orientation or gender identity (33.3% and 33.0%, respectively); experience of sexual violence in a lifetime (30.0% and 27.2%, respectively); 2 to 5 sex partners in the previous three months (31.0% and 34.6%, respectively); unprotected sex at sexual debut (57.8% and 53.7%, respectively); unprotected anal sex in the previous six months (81.0% and 78.6%, respectively); use of hook-up apps in the last three months (63.8% and 71.0%, respectively); at least one STI episode in the last 12 months (16.1% and 22.6%, respectively); previously use of PEP (6.4% and 13.8%, respectively); 46.5% moderate risk perception of HIV infection and 20% high risk perception in both age groups; transactional sex in the previous three months (16.5% and 12.4%, respectively) (Table 1).
February 2019—February 2021.
Among adolescents linked to the PrEP clinics, 87.9% (798) indicated an intention to use oral PrEP, and 87.3% (793) were considered eligible to use PrEP at the first clinical visit. 704 (77.5%) initiated PrEP on the same day. And among the 798 who indicated an intention to use oral PrEP, 721 (90,4%) were considered eligible to start PrEP on the same day.
Among those 15 to 17 years old, 150 (86.2%) indicated an intention to use PrEP, 154 (88.5%) met the clinical criteria for PrEP use and were eligible for same-day PrEP initiation, and 136 (78.2%) initiated at the first visit. Among those 18 and 19 years old, 648 (88.3%) indicated an intention to use PrEP, 639 (87.1%) met the clinical criteria for PrEP use and were eligible for same-day PrEP initiation, 568 (77.4%) initiated at the first visit (Fig 1).
February 2019—February 2021.
In the bivariate analysis, among adolescents aged 15 to 17, black adolescents (82.8%) and those who reported unprotected anal sex (83.7%) had a higher proportion of PrEP initiation (p<0.05). While among adolescents aged 18 and 19, a higher proportion of PrEP initiation (p < 0.05) occurred among those who had experienced violence and discrimination frequently due to sexual orientation or gender identity (83.2%); those who experienced sexual violence in a lifetime (83.2%); those who engaged in transactional sex in the previous three months (86.8%); those who had between 2 to 5 sexual partners in the previous three months (84.6%), and those who reported unprotected anal sex in the previous six months (81.5%) (Table 2).
February 2019—February 2021.
In the multivariate analysis, a statistically significant association with PrEP initiation was found for black adolescents aged 15 to 17 years as compared to non-blacks (PR = 2.31; 95% CI = 1.10–4.84). And among adolescents aged 18 and 19, a statistically significant association with PrEP initiation was estimated for those who engaged in sex in exchange for money or favors in the last 3 months (PR 1.32 =; 95% CI = 1.04–1.68); those who experienced violence and discrimination due to sexual orientation or gender identity (PR = 1.21; 95% CI = 1.01–1.46); those who reported 2 to 5 male sexual partners during the last 3 months (PR = 1.39; 95% CI = 1.15–1.68). Unprotected anal sex in the last 6 months was associated with PrEP initiation in both age groups (15 to 17 years old: PR = 1.98; 95% CI = 1.02–3.85; 18 and 19 years old: PR = 1.45; 95% CI = 1.19–1.76) (Table 3).
February 2019—February 2021.
Discussion
The proportion of PrEP initiation was high among aMSM and aTGW who arrived at services and were enrolled in the cohort, demonstrating the interest and use among participants through active demand creation. This finding is consistent with other studies with adult MSM and TGW, in which PrEP initiation was greater than 60% [49–51]. There is a need to reach and inform a large number of adolescents from the key population about HIV prevention. Twenty percent of adolescent MSM and TGW reached out by the demand creation strategies of PrEP1519 did reach the PrEP clinics [45, 52]. Online interventions can be more cost-effective and easily scaled up to increase service coverage.
Face-to-face recruitment can reach proportionally more underserved adolescents from key populations. In combination, online and peer-driven face-to-face strategies can provide a critical balance between offering comprehensive coverage and equitable sexual health services for adolescents of key populations from different socioeconomic backgrounds [45].
The possibility of starting PrEP on the same day of the first visit may have contributed to the high rate of PrEP initiation among this population, as starting on the same day can increase uptake by reducing the time for PrEP initiation among individuals that are eligible and willing to use it [37, 38]. Studies show that the referral of adolescents to obtain a PrEP prescription at another moment, either in future clinical visits or at another site, causes losses in PrEP initiation rates [53, 54]. It is also important to emphasize that in our study, PrEP was widely promoted through demand creation strategies with the active role of peer educators (adolescents and young MSM or TGW). And the participants were cared for by a multidisciplinary team, which may have increased their PrEP initiation.
The number of black adolescents who started PrEP in the study was more significant than the number of non-blacks. In addition, among those aged 15 to 17 years, there was a strong association between PrEP initiation and self-reported black skin color, which may be related to the range of racial diversity recruitment strategies implemented in the study [45]; an important finding, as black MSMs and TGWs have been more exposed to HIV in several countries around the world [5, 55, 56] and in Brazil [57] due to social inequalities, racial discrimination, and less access to formal education, information, and health services [58, 59].Despite this, the rate of PrEP use in Brazil has been higher among white adults than among blacks [60].
Among adolescents aged 18 to 19, risky sexual practices (having unprotected sex, receiving money or favors in exchange for sex, and the number of sexual partners) and discrimination experiences were associated with PrEP initiation. In both age groups, having unprotected anal intercourse was associated with PrEP initiation, as seen in other studies with adult MSMs and TGWs [50, 61–65].
The practice of unprotected anal sex among adult MSMs and TGWs in Brazil is documented in the literature [17, 66, 67], despite the National Ministry of Health having several campaigns recommending the use of condoms for more than 3 decades [68]. The Brazilian Survey on Knowledge, Attitudes, and Practices among the Brazilian Population (PCAP), carried out in 2013, revealed that about a third of the adolescents and youth aged15 to 24 (36.9%) used a condom during sexual intercourse in the last 12 months, with steady and casual partners, and 19.5% had more than five casual partners in the last twelve months [69]. In our study, we observed a high proportion of unprotected anal sex among aMSM and aTGW, which may also reflect the tendency of a higher HIV risk among younger individuals. Thus, PrEP represents an important prevention strategy for this population.
Transactional sex can be an opportunity for MSM and TGW to have access to material goods and/or represent a means for survival [70, 71]. In this study, we chose to ask youth about receiving money or favors in exchange for sex as a way to indirectly identify those who had transactional sex. Notably, among people under 18, transactional sex represents sexual exploitation [72], defined as a heinous crime in Brazil [73], highlighting an essential problem with violations of fundamental rights among adolescents. In PrEP1519, the health team provided psychosocial care as well as the necessary referrals for minors that reported sexual exploitation. This situation may pose an increased risk of HIV infection [74, 75], as in some cases, the ability to decide on the use of condoms is limited or even discouraged, in response to offers of increased payment for the service [76, 77].
In our study, discrimination was identified as a factor associated with PrEP initiation among adolescents aged 18 to 19. The experience of discrimination due to gender identity and/or sexual orientation is still quite present among adolescents MSM and TGW, in our study as well as in a survey carried out with 521 MSM in the USA, in which about half of the participants revealed such experiences during adolescence [78]. Daily experiences with this discrimination and violence can negatively affect the health of aMSM and aTGW, affecting family bonds [79], the use of condoms in sexual relations (caused by the limited ability to negotiate their use with partners) [17, 80], job opportunities and access to goods and services, especially health care [81, 82].
Our study showed that to promote PrEP uptake and embrace marginalized adolescents who exchange sex for money or favors, who experience discrimination, violence and high-risk sexual practices, culturally sensitive health services that are attentive to the specific demands of the LGBTQIA+ population is fundamental [6, 81, 83, 84]. Therefore, it is increasingly necessary that health professionals are qualified, do not reproduce discriminatory practices at the service facilities [85], and offer a respectful environment, similar to the PrEP1519 care clinics.
During the period of this analysis, the COVID-19 pandemic impacted access to HIV prevention services among key populations in various countries [86, 87], increasing their vulnerability to HIV infection [88]. In the PrEP1519 study, we developed a contingency plan for maintaining the PrEP clinic open, which included the intensification of online recruitment strategies and telehealth during the pandemic [46]. Therefore, the quarantine and physical isolation measures did not significantly impact on the enrollment of adolescents. The proportion of enrolled participants was similar before and after the COVID-19 pandemic [45], as we quickly adapt the online strategies for the pandemic using social media and telemonitoring infrastructure.
Given the above, the PrEP uptake is high among aMSM and aTGW once the method is offered. Considering that these populations are among the most vulnerable to HIV in Brazil and the world [12], and their access to HIV prevention methods are still limited [16, 89], it is necessary to expand access to PrEP worldwide through strategies capable of identifying and linking adolescents in these contexts of vulnerability to offer PrEP.
Limitations
Although we recognize the existence of essential differences between MSM and TGW, our study only included a small proportion of adolescent TGW due to the difficulty in accessing this population that is usually undergoing gender transition processes in this age group [90]. A similarly, it was observed during the enrollment of adolescents aged 15 to 17 years, given the legal requirements established in Salvador and Belo Horizonte cities to include minors in the study, mainly related to the need for consent from parents or legal guardians. The reimbursement for transportation and food costs is an incentive to reach and to link vulnerable adolescents MSM/TGW at high risk of HIV to the PrEP clinics, which may differ in PrEP services from the Brazilian National Health System. In addition, sexual practices, and experiences that are subject to social desirability bias were investigated. The interviewers were trained to maintain an objective and judgment-free language during the application of the questionnaires. Social desirability may have influenced the report of “intention to use PrEP”. Some adolescents may have expressed an intention to use PrEP because they had come to the PrEP clinic, received an incentive, and interacted with clinic staff, but did not intend to initiate PrEP on the same day. All interviews were conducted carefully, in a friendly space, and by an LGBTQIA+ friendly interviewer. The study excluded adolescents with mental illness, although they are also at HIV risk and may use PrEP. So, it is necessary also to investigate their PrEP initiation and use in the future.
Conclusions
This study is the first to assess the PrEP uptake process and factors associated with PrEP initiation among aMSM and aTGW in Brazil. It was possible to observe that socio-behavioral conditions that represent a greater vulnerability to HIV and experiences of violence and discrimination were associated with PrEP initiation. These aspects highlight the need to inform and promote PrEP use, and other HIV combination prevention strategies among aMSM and aTGW at high HIV risk.
In addition, the biggest challenge to promoting the use of PrEP for aMSM and aTGW is in the first steps of the PrEP uptake process, as well as in accessing and linking to care. Once individuals are linked to the PrEP clinic, the prophylaxis initiation rates among them tend to be high. In this sense, the results indicate the challenges the services that offer this prevention strategy need to face as not only identifying but also reaching adolescents at higher HIV risk and promoting access to the prophylaxis, as well as motivating the continued use of PrEP, for whom this prevention strategy may be relevant at a given time in their lives.
Services can use the lessons learned from PrEP1519 to enable PrEP care access and link to HIV prevention, to facilitate effective demand creation strategies among these adolescents. A culturally sensitive approach, attentive to the specific demands of the LGBTQIA+ population is needed. In addition, it is necessary to organize the health service for the other stages of PrEP uptake, and promote the same-day PrEP initiation.
Acknowledgments
We are also grateful to the adolescents in the study and their parents or guardians, and to the Fundação Oswaldo Cruz (Fiocruz Foundation) and Fundação de Apoio à Fiocruz (FIOTEC) that supports the study. The authors would like to acknowledge the local PrEP1519 Brazil Study group: Salvador site—Danielle Medeiros; Equipe clínica: Priscilla Caires, Pedro Rafael Nascimento, Thaís Fonseca, Fabiane Neves Fernandes, Marluce Carvalho, Caffa Cabus; São Paulo site—Paula Massa; Maria Mercedes Escuder, Michelle Claro; Dyemison Pinheiro, Gabriella Durso, Grace SantAnna, Layana Carvalhal, Raphaela Fini, Raphaella Goulart, Regis Alves da Silveira, Tiago Firmino, Victor Guilherme Lopes da Silva Lomba; Belo Horizonte site—Unaí Tupinambás, Mateus Westin, Ana Paula Silva, Marília Greco, Yuppiel Martinez, Érica Dumont.
References
- 1. Bastos FI, Bastos LS, Coutinho C, Toledo L, Mota JC, Velasco-De-Castro CA, et al. HIV, HCV, HBV, and syphilis among transgender women from Brazil: Assessing different methods to adjust infection rates of a hard-to-reach, sparse population. Med (United States). 2018;97(1S): S16–24. pmid:29794601
- 2. Brasil M da S. The Brazilian Response to HIV and AIDS—Global AIDS Response Progress Reporting (GARPR) [Internet]. Brasília; 2015 [cited 2018 Aug 6]. Available from: http://www.unaids.org/sites/default/files/country/documents/BRA_narrative_report_2015.pdf
- 3. Kerr L, Kendall C, Guimarães MDC, Salani Mota R, Veras MA, Dourado I, et al. HIV prevalence among men who have sex with men in Brazil: results of the 2nd national survey using respondent-driven sampling. Medicine (Baltimore) [Internet]. 2018 May [cited 2018 Nov 21];97(1S Suppl 1): S9–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29794604 pmid:29794604
- 4. Landmann Szwarcwald C, Roberta A, Pascom P, Roberto De Souza Júnior P. Estimation of the HIV Incidence and of the Number of People Living With HIV/AIDS in Brazil, 2012. J AIDS Clin Res. 2015; 6:430.
- 5. UNAIDS. GLOBAL AIDS UPDATE Seizing the moment: Tackling entrenched inequalities to end epidemics. Geneva; 2020.
- 6. Mayer KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, Mena L, Reisner S, et al. The persistent and evolving HIV epidemic in American men who have sex with men. Lancet [Internet]. 2021 Feb; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673621003214 pmid:33617771
- 7. Sullivan PS, Satcher Johnson A, Pembleton ES, Stephenson R, Justice AC, Althoff KN, et al. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. Lancet [Internet]. 2021 Feb; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673621003950 pmid:33617774
- 8. Kerr LRFS, Mota RS, Kendall C, De A, Pinho A, Mello MB, et al. HIV among MSM in a large middle-income country. Wolters Kluwer Heal AIDS [Internet]. 2013 [cited 2018 Jun 7];27:427–35. Available from: https://repositorio.ufba.br/ri/bitstream/ri/17700/1/Ines%20Dourado.2013.pdf
- 9. Kerr L, Kendall C, Drew Crosland Guimarães M, Salani Mota R, Amélia Veras M, Dourado I, et al. HIV prevalence among men who have sex with men in Brazil: results of the 2nd national survey using respondent-driven sampling Observational Study. Medicine (Baltimore) [Internet]. 2018 [cited 2018 Jul 9];97:S1. Available from: http://dx.doi.org/10.1097/MD.0000000000010573
- 10. Grinsztejn B, Jalil EM, Monteiro L, Velasque L, Moreira RI, Garcia ACF, et al. Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. Lancet HIV. 2017;4(Issue 4):E169–76. pmid:28188030
- 11. Coelho LE, Torres TS, Veloso VG, Grinsztejn B, Jalil EM, Wilson EC, et al. The Prevalence of HIV Among Men Who Have Sex With Men (MSM) and Young MSM in Latin America and the Caribbean: A Systematic Review. AIDS Behav [Internet]. 2021; Available from: pmid:33587242
- 12. Saffier IP, Kawa H, Harling G. A scoping review of prevalence, incidence and risk factors for HIV infection amongst young people in Brazil. BMC Infect Dis. 2017 Oct 11;17(1):675. pmid:29020929
- 13.
Brasil M da S. Boletim Epidemiológico HIV / Aids | 2020. Vol. 1, Secretaria de Vigilância em Saúde. BRASIL; 2020.
- 14.
Brasil M da S. Protocolo clínico e diretrizes para Profilaxia Pós-Exposição De Risco (PrEP) à infecção pelo HIV,. 1a. Brasília: Ministério da Saúde; 2022. 49 p.
- 15. Brasil M da S. Indicadores e dados básicos do HIV/AIDS nos municípios brasileiros. [Internet]. Ministério da Saúde. 2020 [cited 2021 Feb 14]. Available from: http://indicadores.aids.gov.br/
- 16.
Unaids. UNAIDS DATA 2019. Geneva; 2019.
- 17. Magno L, Dourado I, Silva LAV da, Brignol S, Amorim L, MacCarthy S. Gender- based discrimination and unprotected receptive anal intercourse among transgender women in Brazil: A mixed methods study. Dalby AR, editor. PLoS One [Internet]. 2018 Apr 11 [cited 2018 Jul 24];13(4):e0194306. Available from: http://dx.plos.org/10.1371/journal.pone.0194306
- 18. Magno L, Dourado I, Da Silva LAV. Stigma and resistance among travestis and transsexual women in Salvador, Bahia State, Brazil. Cad Saude Publica. 2018;34(5).
- 19. Altman D, Aggleton P, Williams M, Kong T, Reddy V, Harrad D, et al. Men who have sex with men: stigma and discrimination. Lancet [Internet]. 2012 Jul 28 [cited 2022 Mar 29];380(9839):439–45. Available from: http://www.thelancet.com/article/S0140673612609209/fulltext pmid:22819652
- 20.
Guttmacher Institute. State laws and policies: Sex and HIV education [Internet]. Guttmacher Institute. 2018 [cited 2022 Sep 11]. Available from: https://www.guttmacher.org/state-policy/explore/sex-and-hiv-education
- 21. Raifman J, Beyrer C, Arrington-Sanders R. HIV Education and Sexual Risk Behaviors Among Young Men Who Have Sex with Men. LGBT Heal [Internet]. 2018 Feb 1 [cited 2022 Sep 11];5(2):131–8. Available from: https://pubmed.ncbi.nlm.nih.gov/29297755/ pmid:29297755
- 22. World Health Organization W. CONSOLIDATED GUIDELINE ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION 2016. 2016.
- 23.
World Health Organization W. GUIDANCE ON PRE-EXPOSURE ORAL PROPHYLAXIS (PrEP) FOR SERODISCORDANT COUPLES, MEN AND TRANSGENDER WOMEN WHO HAVE SEX WITH MEN AT HIGH RISK OF HIV: Recommendations for use in the context of demonstration projects [Internet]. World Health Organization. Geneva; 2012 [cited 2018 Feb 8]. Available from: http://apps.who.int/iris/bitstream/10665/75188/1/9789241503884_eng.pdf?ua=1
- 24. Anderson PL, Glidden D V, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med [Internet]. 2012 Sep 12 [cited 2018 May 6];4(151):151–125. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22972843 pmid:22972843
- 25. Grant RM, Lama JR, Anderson PL, Mcmahan V, Liu AY, Vargas L, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N Engl J Med [Internet]. 2010 [cited 2018 May 6];363(27):2587–99. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1011205 pmid:21091279
- 26. Grohskopf LA, Chillag KL, Gvetadze R, Liu AY, Thompson M, Mayer KH, et al. Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States. JAIDS J Acquir Immune Defic Syndr [Internet]. 2013 Sep 1 [cited 2021 Feb 21];64(1):79–86. Available from: https://journals.lww.com/00126334-201309010-00013 pmid:23466649
- 27. Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga J V., Goulart S, et al. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. Lancet HIV. 2018;5(3):e136–45. pmid:29467098
- 28. Hosek SG, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, et al. An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. J Acquir Immune Defic Syndr. 2017;74(1):21–9. pmid:27632233
- 29. Montgomery MC, Oldenburg CE, Nunn AS, Mena L, Anderson P, Liegler T, et al. Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting. PLoS One [Internet]. 2016 [cited 2017 Dec 22];11(6):e0157742. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27333000 pmid:27333000
- 30. Brasil M da S. Protocolo clínico e diretrizes terapêutica para Profilaxia Pré-Exposição (PrEP) de Risco à Infecção pelo HIV. 2017;47. Available from: http://www.aids.gov.br/publicacao/2017/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pre-exposicao-prep-de-ri
- 31. Mullins TLK, Lehmann CE. Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults. Curr Pediatr Rep [Internet]. 2018 Jun [cited 2021 May 4];6(2):114–22. Available from: /pmc/articles/PMC6192052/ pmid:30345163
- 32.
US Food and Drug Administration. Truvada supplement approval [Internet]. 2018 Aug [cited 2021 May 4]. Available from: http://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/default.htm
- 33. Ezennia O, Geter A, Smith DK. The PrEP Care Continuum and Black Men Who Have Sex with Men: A Scoping Review of Published Data on Awareness, Uptake, Adherence, and Retention in PrEP Care. Vol. 23, AIDS and Behavior. 2019. p. 2654–73. pmid:31463711
- 34. Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, Mimiaga M, Patel R, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS. 2017;31(05).
- 35. CDC-US C for DC and PUPHS. Preexposure prophylaxis for the prevention of HIV infection in the United States-2017: Update a clinical practice guideline [Internet]. 2018. Available from: https://www.cdc.gov/std/tg2015/tg-2015-
- 36. Kamis KF, Marx GE, Scott KA, Gardner EM, Wendel KA, Scott ML, et al. Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care. Open Forum Infect Dis [Internet]. 2019 [cited 2021 May 17]; Available from: https://academic.oup.com/ofid/article-abstract/6/7/ofz310/5524450 pmid:31341933
- 37. Khosropour CM, Backus K V., Means AR, Beauchamps L, Johnson K, Golden MR, et al. A Pharmacist-Led, Same-Day, HIV Pre-Exposure Prophylaxis Initiation Program to Increase PrEP Uptake and Decrease Time to PrEP Initiation. AIDS Patient Care STDS [Internet]. 2020 Jan 1 [cited 2021 May 3];34(1):1–6. Available from: https://pubmed.ncbi.nlm.nih.gov/31944854/ pmid:31944854
- 38. Mikati T, Jamison K, Daskalakis D. Immediate PrEP Initiation at New York city Sexual Health Clinics. In: Conference on Retroviruses and Opportunistic Infections. Seattle; 2019. p. 962.
- 39.
Rowan SE, Patel RR, Schneider JA, Smith DK. Same-day prescribing of daily oral pre- exposure prophylaxis for HIV prevention [Internet]. Vol. 8, The Lancet HIV. Elsevier Ltd; 2021 [cited 2021 May 23]. p. e114–20. Available from: http://www.thelancet.com/article/S2352301820302563/fulltext
- 40.
Veloso VG, Vega-Ramírez EH, Hoagland B, Konda KA, Bautista-Arredondo S, Guanira JV, et al. Safety, early continuation and adherence of same day PrEP initiation among MSM and TGW in Brazil, Mexico and Peru: the ImPrEP Study. In: International Aids Society. México; 2019.
- 41. Han J, Bouey JZH, Wang L, Mi G, Chen Z, He Y, et al. PrEP uptake preferences among men who have sex with men in China: results from a National Internet Survey. J Int AIDS Soc. 2019 Feb 1;22(2). pmid:30724470
- 42. Morgan E, Moran K, Ryan DT, Mustanski B, Newcomb ME. Threefold Increase in PrEP Uptake Over Time with High Adherence Among Young Men Who Have Sex With Men in Chicago. AIDS Behav [Internet]. 2018 Nov 1 [cited 2021 May 4];22(11):3637–44. Available from: /pmc/articles/PMC6204095/ pmid:29728949
- 43. Strauss BB, Greene GJ, Phillips G, Bhatia R, Madkins K, Parsons JT, et al. Exploring Patterns of Awareness and Use of HIV Pre-Exposure Prophylaxis Among Young Men Who Have Sex with Men. AIDS Behav [Internet]. 2017 May 1 [cited 2021 May 4];21(5):1288–98. Available from: /pmc/articles/PMC5226918/ pmid:27401537
- 44. Mensch BS, Straten A van der, Katzen LL. Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS [Internet]. 2012 Nov [cited 2018 May 6];7(6):534–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23032737 pmid:23032737
- 45. Magno L, Soares F, Zucchi EM, Eustorgio M, Grangeiro A, Ferraz D, et al. Reaching adolescents at high risk of HIV infection in Brazil: demand creation strategies for PrEP and other combination prevention methods enrolment among adolescent men who have sex with men and transgender women. Arch Sex Behav. 2021;(under review).
- 46. Dourado I, Magno L, Soares F, Massa P, Nunn A, Dalal S, et al. Adapting to the COVID-19 Pandemic: Continuing HIV Prevention Services for Adolescents Through Telemonitoring, Brazil. AIDS Behav [Internet]. 2020 Jul 1 [cited 2021 Aug 29];24(7):1994–9. Available from: https://pubmed.ncbi.nlm.nih.gov/32440973/ pmid:32440973
- 47. Amorim LD. Package “prLogistic” Title Estimation of Prevalence Ratios using Logistic Models [Internet]. 2015 [cited 2021 Mar 22]. Available from: http://www.umass.edu/statdata/statdata/stat-
- 48.
Hosmer DW, Lemeshow S. Applied Logistic Regression [Internet]. 2nd ed. New York: Wiley Interscience Publication; 2000 [cited 2018 May 6]. 376 p. Available from: http://resource.heartonline.cn/20150528/1_3kOQSTg.pdf
- 49. Chan PA, Glynn TR, Oldenburg CE, Montgomery MC, Robinette AE, Almonte A, et al. Implementation of Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention among Men Who Have Sex with Men at a New England Sexually Transmitted Diseases Clinic. Sex Transm Dis [Internet]. 2016 Nov 1 [cited 2021 May 4];43(11):717–23. Available from: https://pubmed.ncbi.nlm.nih.gov/27893604/ pmid:27893604
- 50. Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. Lancet Infect Dis [Internet]. 2014;14(9):820–9. Available from: pmid:25065857
- 51. Hoagland B, Moreira RI, De Boni RB, Kallas EG, Madruga JV, Vasconcelos R, et al. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project. J Int AIDS Soc [Internet]. 2017 [cited 2021 Jul 14];20(1). Available from: https://pubmed.ncbi.nlm.nih.gov/28418232/ pmid:28418232
- 52.
Magno L, Soares F, Eustórgio M, Grangeiro A, Ferraz D, Zucchi EM, et al. Effectiveness of strategies for generating demand for PrEP and combination prevention among adolescent´s men who have sex with men and transgender women in Brazil. In: 11th Aids Conference on HIV Science. Berlin; 2021.
- 53. Bhatia R, Modali L, Lowther M, Glick N, Bell M, Rowan S, et al. Outcomes of Preexposure Prophylaxis Referrals from Public STI Clinics and Implications for the Preexposure Prophylaxis Continuum. Sex Transm Dis [Internet]. 2018 Jan 1 [cited 2021 May 25];45(1):50–5. Available from: https://journals.lww.com/stdjournal/Fulltext/2018/01000/Outcomes_of_Preexposure_Prophylaxis_Referrals_From.12.aspx pmid:28876282
- 54. Mayer CM, Owaraganise A, Kabami J, Kwarisiima D, Koss CA, Charlebois ED, et al. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda. J Int AIDS Soc. 2019 Apr 1;22(4).
- 55. Dougan S, Elford J, Rice B, Brown AE, Sinka K, Evans BG, et al. Epidemiology of HIV among black and minority ethnic men who have sex with men in England and Wales. Sex Transm Infect [Internet]. 2005 Aug [cited 2021 May 30];81(4):345–50. Available from: www.stijournal.com pmid:16061545
- 56. Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, et al. Risk factors for HIV infection among men who have sex with men [Internet]. 2006. Available from: www.explorestudy.org
- 57. Andrade JS, Lima G dos S, Oliveira FBM. Analysis of the vulnerability factors to HIV / AIDS infection in the black population. ReonFacema. 2018;4(3):986–92.
- 58. Fry PH, Monteiro S, Maio MC, Bastos FI, Santos RV. Does AIDS have a race or color? Data interpretationand health policymaking in Brazil. Debate. 2007;23(03):497–523.
- 59. Pascom ARP, Meireles MV, Benzaken AS. Sociodemographic determinants of attrition in the HIV continuum of care in Brazil, in 2016. Med (United States) [Internet]. 2018 May 1 [cited 2021 May 30];97(1S):S69–74. Available from: /pmc/articles/PMC5991540/
- 60. Brasil M da S. Painel PrEP | Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis [Internet]. Departamento de Condições Crônicas e Infecções Sexualmente Transmissíveis. 2021 [cited 2021 Jul 29]. Available from: http://www.aids.gov.br/pt-br/painel-prep
- 61. Cohen SE, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle BS, Feaster DJ, et al. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: Baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr [Internet]. 2015 Apr 1 [cited 2020 Nov 30];68(4):439–48. Available from: /pmc/articles/PMC4334721/?report = abstract pmid:25501614
- 62. Golub S, Fikslin R, Goldberg M, Peña S, Radix A. Predictors of PrEP Uptake Among Patients with Equivalent Access. AIDS Behav [Internet]. 2019 Jul 15 [cited 2021 Jul 14];23(7):1917–24. Available from: https://pubmed.ncbi.nlm.nih.gov/30600456/ pmid:30600456
- 63. Krakower DS, Mimiaga MJ, Rosenberger JG, Novak DS, Mitty JA, White JM, et al. Limited Awareness and Low Immediate Uptake of Pre- Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site. PLoS One [Internet]. 2012 [cited 2018 Mar 31];7(3). Available from: http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0033119&type=printable pmid:22470438
- 64. Serota DP, Rosenberg ES, Sullivan PS, Thorne AL, Rolle CPM, Del Rio C, et al. Pre- exposure prophylaxis uptake and discontinuation among young black men who have sex with men in atlanta, Georgia: A prospective cohort study. Clin Infect Dis. 2020 Aug 1;71(3):574–82. pmid:31499518
- 65. Wahome E, Graham S, Thiong’o A, Chirro O, Mohamed K, Gichuru E, et al. Assessment of PrEP eligibility and uptake among at-risk MSM participating in a HIV- 1 vaccine feasibility cohort in coastal Kenya. Wellcome Open Res. 2020 Sep 19;4:138. pmid:32140565
- 66. Dourado I, Maccarthy S, Reddy M, Calazans G, Gruskin S. Revisitando o uso do preservativo no Brasil [Internet]. Vol. 18, Revista Brasileira de Epidemiologia. Assocaicao Brasileira de Pos, Gradacao em Saude Coletiva; 2015 [cited 2021 Mar 7]. p. 63–88. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2015000500063&lng=en&nrm=iso&tlng=en
- 67. Guimarães MDC, Kendall C, Magno L, Rocha GM, Knauth DR, Leal AF, et al. Comparing HIV risk-related behaviors between 2 RDS national samples of MSM in Brazil, 2009 and 2016. Medicine (Baltimore) [Internet]. 2018 May [cited 2018 Nov 21];97(1S Suppl 1):S62–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29912816 pmid:29912816
- 68. Marinho MB. Between functionality and playfulness: condom in aids prevention campaigns. Interface: Communication, Health, Education [Internet]. 2000 Feb; 4 (6). Available from: https://www.scielo.br/j/icse/a/hG5yHvXhFQMRH6KQqbzgr5K/?lang=pt
- 69.
Brasil M da S. Pesquisa de Conhecimentos, Atitudes e Práticas na População Brasileira (PCAP) [Internet]. Brasília: Ministério da Saúde; 2016. p. 166. Available from: file:///C:/Users/USUARIO1/Downloads/pcap_2013.pdf
- 70. Nadal KL, Davidoff KC, Fujii-Doe W. Transgender Women and the Sex Work Industry: Roots in Systemic, Institutional, and Interpersonal Discrimination. J Trauma Dissociation [Internet]. 2014 [cited 2021 Mar 23];15(2):169–83. Available from: https://pubmed.ncbi.nlm.nih.gov/24313294/ pmid:24313294
- 71. Tucker C, Galindo Arandi C, Herbert Bolaños J, Paz-Bailey G, Barrington C. Understanding social and sexual networks of sexual minority men and transgender women in Guatemala City to improve HIV prevention efforts. J Health Care Poor Underserved [Internet]. 2014 [cited 2021 Mar 23];25(4):1698–717. Available from: /pmc/articles/PMC4310554/ pmid:25418236
- 72. Brasil P da R. Lei No 8.069, de 13 de Julho de 1990. Dispõe sobre o Estatuto da Criança e do Adolescente e dá outras providências. [Internet]. Distrito Federal; 1990 [cited 2021 Jul 29]. Available from: http://www.planalto.gov.br/ccivil_03/leis/l8069.htm
- 73. Brasil P da R. Lei No 8.072 de 25 de Julho de 1990. Dispõe sobre os crimes hediondos, nos termos do art. 5o, inciso XLIII, da Constituição Federal, e determina outras providências. 1990.
- 74. Zheng C, Xu J-J, Hu Q, Yu Y, Chu Z, Zhang J, et al. Commercial sex and risk of HIV, syphilis, and herpes simplex virus-2 among men who have sex with men in six Chinese cities. BMC Infect Dis [Internet]. 2016 Dec 21 [cited 2021 Jul 29];16(1). Available from: https://pubmed.ncbi.nlm.nih.gov/28003032/ pmid:28003032
- 75. Feng Y, Bu K, Li M, Zhang X, Jin S, Wang L. [Meta-analysis of HIV infection incidence and risk factors among men who have sex with men in China]. Zhonghua Liu Xing Bing Xue Za Zhi [Internet]. 2015 [cited 2021 Jul 29];36(7):752–8. Available from: https://pubmed.ncbi.nlm.nih.gov/26564708/ pmid:26564708
- 76.
Vuylsteke B, Jana S. Reducing HIV Risk in Sex Workers, Their Clients and Partners. In: HIV/AIDS Prevention and Care in Resource-Constrained Settings. WHO, World Health Organization; 2001. p. 26.
- 77. Yi S, Plant A, Tuot S, Mun P, Chhim S, Chann N, et al. Factors associated with condom use with non-commercial partners among sexually-active transgender women in Cambodia: Findings from a national survey using respondent-driven sampling. BMC Public Health [Internet]. 2019 Mar 20 [cited 2021 Mar 23];19(1):326. Available from: https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-019-6656-x pmid:30894165
- 78. Raymond HF, Chen YH, Stall RD, McFarland W. Adolescent experiences of discrimination, harassment, connectedness to community and comfort with sexual orientation reported by adult men who have sex with men as a predictor of adult HIV status. AIDS Behav. 2011;15(3):550–6. pmid:19915973
- 79. de Souza MHT, Malvasi P, Signorelli MC, Pereira PPG. Violência e sofrimento social no itinerário de travestis de Santa Maria, Rio Grande do Sul, Brasil. Cad Saude Publica [Internet]. 2015 [cited 2021 Mar 21];31(4):767–76. Available from: https://pubmed.ncbi.nlm.nih.gov/25945986/
- 80. Magno L, Dourado I, da Silva LA V., Brignol S, Brito AM de, Guimarães MDC, et al. Factors associated with self-reported discrimination against men who have sex with men in Brazil. Rev Saude Publica [Internet]. 2017 [cited 2021 Mar 22];51:102. Available from: /pmc/articles/PMC5697921/ pmid:29166436
- 81. Balik CAB, Bilgin H, Tekin Uluman O, Sukut O, Yilmaz S, Buzlu S. A Systematic Review of the Discrimination Against Sexual and Gender Minority in Health Care Settings. Int J Heal. 2020;50(1):44–6.
- 82. Monteiro S, Brigeiro M. Experiences of transgender women/transvestites with access to health services: Progress, limits, and tensions. Cad Saude Publica. 2019;35(4).
- 83. Van der Elst EM, Gichuru E, Muraguri N, Musyoki H, Micheni M, Kombo B, et al. Strengthening healthcare providers’ skills to improve HIV services for MSM in Kenya. AIDS [Internet]. 2015 Dec 1 [cited 2021 Mar 21];29(Supplement 3):S237–40. Available from: https://journals.lww.com/00002030-201512003-00006 pmid:26372492
- 84.
Reisner SL, Poteat T, Keatley JA, Cabral M, Mothopeng T, Dunham E, et al. Global health burden and needs of transgender populations: a review [Internet]. Vol. 388, The Lancet. Lancet Publishing Group; 2016 [cited 2021 Mar 23]. p. 412–36. Available from: /pmc/articles/PMC7035595/
- 85. Van der Elst EM, Smith AD, Gichuru E, Wahome E, Musyoki H, Muraguri N, et al. Men who have sex with men sensitivity training reduces homoprejudice and increases knowledge among Kenyan healthcare providers in coastal Kenya. J Int AIDS Soc. 2013 Dec 2;16:18748. pmid:24321111
- 86. Rao A, Rucinski K, Jarrett BA, Ackerman B, Wallach S, Marcus J, et al. Perceived Interruptions to HIV Prevention and Treatment Services Associated with COVID-19 for Gay, Bisexual, and Other Men Who Have Sex with Men in 20 Countries. J Acquir Immune Defic Syndr [Internet]. 2021 May 1 [cited 2022 Sep 13];87(1):644–51. Available from: https://journals.lww.com/jaids/Fulltext/2021/05010/Perceived_Interruptions_to_HIV_Prevention_and.2.aspx pmid:33443963
- 87. Sanchez TH, Zlotorzynska M, Rai M, Baral SD. Characterizing the Impact of COVID- 19 on Men Who Have Sex with Men Across the United States in April, 2020. AIDS Behav [Internet]. 2020 Jul 1 [cited 2022 Sep 13];24(7):2024–32. Available from: https://link.springer.com/article/10.1007/s10461-020-02894-2 pmid:32350773
- 88.
Grangeiro A, Magno, Escuder MM, Miura Zucchi E, Koyama M, Massa P, et al. High risk sexual behavior, access to HIV prevention services and HIV incidence during the COVID-19 pandemic among men who have sex with men and transgender women in Brazil. In: 11th IAS Confer-ence on HIV Science, editor. 11th IAS Conference on HIV Science [Internet]. Berlim; 2021 [cited 2022 Sep 13]. Available from: https://theprogramme.ias2021.org/Abstract/Abstract/1187
- 89.
CDC C for DC and P. Compendium of evidence-based interventions and best practices for HIV prevention. [Internet]. CDC. 2017 [cited 2022 Sep 11]. Available from: https://www.cdc.gov/hiv/research/interventionresearch/compendium/index.html
- 90. Giovanardi G, Morales P, Mirabella M, Fortunato A, Chianura L, Speranza AM, et al. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty. J Endocrinol Investig 2019 4210 [Internet]. 2019 Apr 5 [cited 2021 Jul 25];42(10):1231–40. Available from: https://link.springer.com/article/10.1007/s40618-019-01045-2